Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,226 | -5,030 | -1,053 | -995 | -3,419 |
| Depreciation Amortization | 3,122 | 2,745 | 2,849 | 2,879 | 3,260 |
| Accounts receivable | 1,250 | -1,675 | -66 | 21 | -204 |
| Other Working Capital | -1,665 | -5,542 | -504 | -47 | 200 |
| Other Operating Activity | 339 | 3,117 | 515 | 298 | 737 |
| Operating Cash Flow | $-4,180 | $-6,385 | $1,741 | $2,156 | $574 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 134 |
| PPE Investments | -1,623 | -1,751 | -2,697 | -2,667 | -2,674 |
| Net Acquisitions | N/A | N/A | N/A | -160 | -200 |
| Purchase Sale Intangibles | N/A | -150 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -150 | 0 | 50 | -50 |
| Investing Cash Flow | $-1,623 | $-1,901 | $-2,697 | $-2,777 | $-2,790 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,737 | 6,049 | 1,607 | 0 | 123 |
| Debt Repayment | -4,676 | -2,348 | -184 | -357 | -459 |
| Common Stock Issued | N/A | 6,413 | 2,343 | 2,310 | 36 |
| Other Financing Activity | -81 | -33 | -16 | -1 | 0 |
| Financing Cash Flow | $1,980 | $10,081 | $3,750 | $1,952 | $-300 |
| Exchange Rate Effect | -139 | -65 | -60 | 16 | -16 |
| Beginning Cash Position | 7,185 | 5,455 | 2,721 | 1,374 | 3,906 |
| End Cash Position | 3,223 | 7,185 | 5,455 | 2,721 | 1,374 |
| Net Cash Flow | $-3,962 | $1,730 | $2,734 | $1,347 | $-2,532 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,180 | -6,385 | 1,741 | 2,156 | 574 |
| Capital Expenditure | -1,632 | -1,751 | -2,697 | -2,667 | -2,674 |
| Free Cash Flow | -5,812 | -8,136 | -956 | -511 | -2,100 |